BRIAN J. MCNAMARA

Corporate Board Profile

Tech Score: 0/100

Mondelez International, Inc.

Filing Date	Source Excerpt
2024-04-05	Mr. McNamara has served as Chief Executive Officer of Haleon plc (formerly GSK ConsumerHealthcare), a global consumer healthcare company, since May 2022. Mr. McNamara joined GlaxoSmithKline plc, a global pharmaceutical and biotechnology company, in 2015 and served in various capacities, including Chief Executive Officer Designate, Haleon, from July 2021 to May 2022, Chief Executive Officer, GSK Consumer Healthcare from October 2016 to May 2021 and Head of Europe and Americas, GSK Consumer Healthcare from March 2015 to September 2016.
2025-04-04	Mr. McNamara has gained valuable experience in executive leadership and global operations management. He has a strong track record of building and marketing global brands.

Filing Date

Source Excerpt

2024-04-05

Mr. McNamara has served as Chief Executive Officer of Haleon plc (formerly GSK ConsumerHealthcare), a global consumer healthcare company, since May 2022. Mr. McNamara joined GlaxoSmithKline plc, a global pharmaceutical and biotechnology company, in 2015 and served in various capacities, including Chief Executive Officer Designate, Haleon, from July 2021 to May 2022, Chief Executive Officer, GSK Consumer Healthcare from October 2016 to May 2021 and Head of Europe and Americas, GSK Consumer Healthcare from March 2015 to September 2016.

2025-04-04

Mr. McNamara has gained valuable experience in executive leadership and global operations management. He has a strong track record of building and marketing global brands.

Data sourced from SEC filings. Last updated: 2026-02-03